Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
HemeNatal OB
Overview
What is HemeNatal OB?
What does HemeNatal OB look like?

What are the available doses of HemeNatal OB?
Sorry No records found.
What should I talk to my health care provider before I take HemeNatal OB?
Sorry No records found
How should I use HemeNatal OB?
One tablet daily with or without food or as prescribed by a physician.
What interacts with HemeNatal OB?
Sorry No Records found
What are the warnings of HemeNatal OB?
Sorry No Records found
What are the precautions of HemeNatal OB?
Sorry No Records found
What are the side effects of HemeNatal OB?
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
What should I look out for while using HemeNatal OB?
What might happen if I take too much HemeNatal OB?
Sorry No Records found
How should I store and handle HemeNatal OB?
Store at 20°-25°C (68°-77°F) (see USP Controlled Room Temperature). Avoid freezing and protect from light.Dicyclomine Hydrochloride Capsules, USP, 10 mg are supplied as dark blue capsules printed "West-ward 3126" and are available in:Bottles of 100 capsules.Bottles of 1000 capsules.Dicyclomine Hydrochloride Tablets, USP 20 mg are supplied as Blue, Round Tablets; Embossed "WW27" and are available in:Bottles of 100 tablets.Bottles of 1000 tablets.Unit Dose Boxes of 100 tablets. Dicyclomine Hydrochloride Capsules, USP, 10 mg are supplied as dark blue capsules printed "West-ward 3126" and are available in:Bottles of 100 capsules.Bottles of 1000 capsules.Dicyclomine Hydrochloride Tablets, USP 20 mg are supplied as Blue, Round Tablets; Embossed "WW27" and are available in:Bottles of 100 tablets.Bottles of 1000 tablets.Unit Dose Boxes of 100 tablets.
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Non-Clinical Toxicology
Drugs With Ototoxic Potential (see )Especially in the presence of impaired renal function, the use of parenterally administered bumetanide in patients to whom aminoglycoside antibiotics are also being given should be avoided, except in life-threatening conditions.
Drugs With Nephrotoxic Potential
There has been no experience with the concurrent use of bumetanide with drugs known to have a nephrotoxic potential. Therefore, the simultaneous administration of these drugs should be avoided.
Lithium
Lithium should generally not be given with diuretics (such as bumetanide) because they reduce its renal clearance and add a high risk of lithium toxicity.
Probenecid
Pretreatment with probenecid reduces both the natriuresis and hyperreninemia produced by bumetanide. This antagonistic effect of probenecid on bumetanide natriuresis is not due to a direct action on sodium excretion but is probably secondary to its inhibitory effect on renal tubular secretion of bumetanide. Thus, probenecid should not be administered concurrently with bumetanide.
Indomethacin
Indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide-induced increase in plasma renin activity. Concurrent therapy with bumetanide is thus not recommended.
Antihypertensives
Bumetanide may potentiate the effect of various antihypertensive drugs, necessitating a reduction in the dosage of these drugs.
Digoxin
Interaction studies in humans have shown no effect on digoxin blood levels.
Anticoagulants
Interaction studies in humans have shown bumetanide to have no effect on warfarin metabolism or on plasma prothrombin activity.
KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).